Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network study

•We evaluated people with suspected hypersensitivity after COVID-19 vaccination.•92% of 180 referred for hypersensitivity reactions were recommended for revaccination.•85% with physician-diagnosed hypersensitivity had no recurrent symptoms after revaccination.•Patients with COVID-19 vaccine hypersen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2024-10, Vol.42 (24), p.126078, Article 126078
Hauptverfasser:	Fitzpatrick, Tiffany, Yamoah, Peter, Lacuesta, Gina, Sadarangani, Manish, Cook, Victoria, Pourshahnazari, Persia, Kalicinsky, Chrystyna, Upton, Julia E.M., Cameron, Scott B., Zaborniak, Karver, Kanani, Amin, Lam, Godfrey, Burton, Catherine, Constantinescu, Cora, Pernica, Jeffrey M., Abdurrahman, Zainab, Betschel, Stephen, Drolet, Jean-Philippe, De Serres, Gaston, Quach, Caroline, Des Roches, Anne, Chapdelaine, Hugo, Salvadori, Marina I., Carignan, Alex, McConnell, Athena, Pham-Huy, Anne, Buchan, C. Arianne, Cowan, Juthaporn, Hildebrand, Kyla, Top, Karina A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescents Adverse event following immunization Adverse events Allergies Anaphylaxis Asparaginase Consent Contraindications COVID-19 COVID-19 infection COVID-19 vaccines Data collection Hypersensitivity Hypersensitivity (immediate) Immunization Infectious diseases Medical referrals Medical research mRNA mRNA vaccine mRNA vaccines Patients Physicians polyethylene Polyethylene glycol Public health Risk assessment Signs and symptoms Skin Vaccination Vaccines Viral vector vaccine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!